Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo - PubMed (original) (raw)
Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo
A H Fairlamb et al. Mol Biochem Parasitol. 1980 Oct.
Abstract
After a single intravenous injection of suramin the rate of removal of the drug from the plasma into other tissue compartments of the rat is independent of initial concentration. The data can be fitted to the sum of two exponential functions, consistent with a two-compartment, open model system. Trypanosomes take up only small amounts of suramin in vivo and do not actively concentrate the drug within the cell. Uptake is apparently by a non-saturable process that decreases with time and is dependent on the amount of suramin already taken up. Once within the cell, suramin progressively inhibits respiration and glycolysis, such that, for a given exposure in vivo, inhibition of oxygen consumption is proportional to the total amount of suramin absorbed. It can be calculated that only a fraction (4--9%) of this total is required to inhibit respiration to the extent found in broken cell preparations. The combined inhibition of two key enzymes in glycolysis--the sn-glycerol-3-phosphate oxidase (EC unassigned) and the glycerol-3-phosphate dehydrogenase (NAD+) (sn-glycerol-3-phosphate: NAD+ 2-oxidoreductase, EC 1.1.1.8)--are sufficient to account for the differential inhibition of glucose and oxygen consumption and of pyruvate production, together with the small, but significant, production of glycerol. Even at the highest dose of suramin tolerated by the rat, trypanosomes continue to increase exponentially in the bloodstream for at least 6 h. The mean doubling time is increased from 4.6 h to a maximum of about 12.5 h in rats treated with doses of suramin in the range 25--150 mg/kg. In the light of these and other findings, it is concluded that part of the trypanocidal action of suramin results from the inhibition of ATP production by glycolysis.
Similar articles
- An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei.
Minagawa N, Yabu Y, Kita K, Nagai K, Ohta N, Meguro K, Sakajo S, Yoshimoto A. Minagawa N, et al. Mol Biochem Parasitol. 1997 Feb;84(2):271-80. doi: 10.1016/s0166-6851(96)02797-1. Mol Biochem Parasitol. 1997. PMID: 9084049 - An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei.
Minagawa N, Yabu Y, Kita K, Nagai K, Ohta N, Meguro K, Sakajo S, Yoshimoto A. Minagawa N, et al. Mol Biochem Parasitol. 1996 Oct 30;81(2):127-36. doi: 10.1016/0166-6851(96)02665-5. Mol Biochem Parasitol. 1996. PMID: 8898329 Corrected and republished. - Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs.
Bakker BM, Westerhoff HV, Opperdoes FR, Michels PA. Bakker BM, et al. Mol Biochem Parasitol. 2000 Feb 25;106(1):1-10. doi: 10.1016/s0166-6851(99)00197-8. Mol Biochem Parasitol. 2000. PMID: 10743606 Review. - Regulation and control of compartmentalized glycolysis in bloodstream form Trypanosoma brucei.
Bakker BM, Westerhoff HV, Michels PA. Bakker BM, et al. J Bioenerg Biomembr. 1995 Oct;27(5):513-25. doi: 10.1007/BF02110191. J Bioenerg Biomembr. 1995. PMID: 8718456 Review.
Cited by
- Biogenesis of glycosomes of Trypanosoma brucei: an in vitro model of 3-phosphoglycerate kinase import.
Dovey HF, Parsons M, Wang CC. Dovey HF, et al. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2598-602. doi: 10.1073/pnas.85.8.2598. Proc Natl Acad Sci U S A. 1988. PMID: 3282231 Free PMC article. - Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis.
Bowling T, Mercer L, Don R, Jacobs R, Nare B. Bowling T, et al. Int J Parasitol Drugs Drug Resist. 2012 Mar 3;2:262-70. doi: 10.1016/j.ijpddr.2012.02.002. eCollection 2012 Dec. Int J Parasitol Drugs Drug Resist. 2012. PMID: 24533287 Free PMC article. - Synthesis and Anti-Trypanosoma cruzi Activity of New Pyrazole-Thiadiazole Scaffolds.
Souza TP, Orlando LMR, Lara LDS, Paes VB, Dutra LP, Dos Santos MS, Pereira MCS. Souza TP, et al. Molecules. 2024 Jul 27;29(15):3544. doi: 10.3390/molecules29153544. Molecules. 2024. PMID: 39124949 Free PMC article. - HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Stevens M, Abdeen S, Salim N, Ray AM, Washburn A, Chitre S, Sivinski J, Park Y, Hoang QQ, Chapman E, Johnson SM. Stevens M, et al. Bioorg Med Chem Lett. 2019 May 1;29(9):1106-1112. doi: 10.1016/j.bmcl.2019.02.028. Epub 2019 Feb 28. Bioorg Med Chem Lett. 2019. PMID: 30852084 Free PMC article. - Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.
Barrett MP, Boykin DW, Brun R, Tidwell RR. Barrett MP, et al. Br J Pharmacol. 2007 Dec;152(8):1155-71. doi: 10.1038/sj.bjp.0707354. Epub 2007 Jul 9. Br J Pharmacol. 2007. PMID: 17618313 Free PMC article. Review.